Literature DB >> 11295789

Impact of Huntington's disease on quality of life.

D I Helder1, A A Kaptein, G M van Kempen, J C van Houwelingen, R A Roos.   

Abstract

The purpose of this study was to systematically assess the impact of Huntington's disease (HD) on patients' health-related quality of life (QOL). Seventy-seven patients with a clinically confirmed diagnosis of HD were interviewed by means of the Sickness Impact Profile (SIP). Additional data were gathered on patients' motor performance by means of the motor section of the Unified Huntington Disease Rating Scale (UHDRS), and cognitive performance by means of the Mini-Mental State (MMS). Patients had high scores on the SIP subscales, indicating moderate to severe functional impairment. Total Motor Score (TMS), MMS scores, and the duration of HD were significantly correlated with patients' scores on the SIP, and predicted a significant amount of variance of the Physical Dimension of the SIP, but not of the Psychosocial Dimension. We conclude that HD has a great impact on patients' physical and psychosocial well-being, the latter being more severely affected. Implications for further research and clinical practice are discussed. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2001        PMID: 11295789     DOI: 10.1002/mds.1056

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers.

Authors:  Marita P McCabe; Lucy Firth; Elodie O'Connor
Journal:  J Clin Psychol Med Settings       Date:  2009-07-29

3.  Perceived stress in prodromal Huntington disease.

Authors:  Nancy Downing; Megan M Smith; Leigh J Beglinger; James Mills; Kevin Duff; Kelly C Rowe; Eric Epping; Jane S Paulsen
Journal:  Psychol Health       Date:  2011-06-21

4.  Onset of Huntington's disease: can it be purely cognitive?

Authors:  Jane S Paulsen; Jeffrey D Long
Journal:  Mov Disord       Date:  2014-08-20       Impact factor: 10.338

5.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

6.  Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.

Authors:  Noelle E Carlozzi; Elizabeth A Hahn; Siera M Goodnight; Anna L Kratz; Jane S Paulsen; Julie C Stout; Samuel Frank; Jennifer A Miner; David Cella; Richard C Gershon; Stephen G Schilling; Rebecca E Ready
Journal:  Psychol Assess       Date:  2017-05-29

7.  Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period.

Authors:  Sarah L Mason; Ruwani Wijeyekoon; Rachel Swain; Aileen K Ho; Emma L Smith; Barbara Sahakian; Roger A Barker
Journal:  PLoS Curr       Date:  2010-09-02

8.  Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease.

Authors:  Guilherme Riccioppo Rodrigues; Carolina Pinto Souza; Roberto Satler Cetlin; Daniel Sabino de Oliveira; Marcio Pena-Pereira; Liliana Tiemi Ujikawa; Wilson Marques; Vitor Tumas
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

9.  Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.

Authors:  Dana Rizk; Claudine Jurkovitz; Emir Veledar; Susan Bagby; Deborah A Baumgarten; Frederic Rahbari-Oskoui; Theodore Steinman; Arlene B Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

10.  Patient and caregiver quality of life in Huntington's disease.

Authors:  Rebecca E Ready; Melissa Mathews; Anne Leserman; Jane S Paulsen
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.